114 · Documents & Contracts
Vendor and supply agreements for psilocybin manufacturers and labs
Last reviewed: August 2026 · Psychedelic law changes quickly — verify current status before relying on this page.
Who this is for: Oregon and Colorado licensed manufacturers, laboratories, and service center operators who buy or sell psilocybin product or testing services, and the lawyers who draft the contracts between them.
The short answer
Psilocybin product moves through a closed chain of state-licensed parties: manufacturers who produce it, laboratories who test it, and service centers who administer it. The agreements among them are supply and testing contracts written for that regulated chain. Every party to such an agreement must hold and keep a state license, the product cannot cross state lines, and the contract has to track the state’s testing, transport, and recordkeeping rules. Beyond those constraints, the agreements handle the ordinary commercial questions of specification, price, payment, and what happens when product is defective.
The licensed supply chain
In Oregon and Colorado, psilocybin product is produced, tested, and administered only by licensed parties, and it can be transferred only between them. A service center buys product from a licensed manufacturer, a manufacturer sends product to a licensed laboratory for required testing, and the chain is tracked from production to administration. Vendor agreements sit at each link: a supply agreement between manufacturer and service center, a testing agreement between manufacturer and laboratory, and ordinary vendor contracts for packaging, security, and software. Each agreement assumes the regulated structure that an ordinary supply contract would not.
Licensure as a condition of the whole agreement
Because only licensed parties can hold or transfer product, every obligation in the agreement depends on the parties keeping their licenses. The contract should require each party to represent that it holds the necessary license and to keep that license in force, and it should suspend transfers immediately if a party’s license lapses, is suspended, or is revoked. A supply agreement that does not condition performance on licensure can require a party to do something the law no longer permits. The agreement should also let either side terminate if the other loses its license, and should address what happens to product in transit or in inventory when that occurs.
Product specifications and testing
The agreement defines what the manufacturer is supplying: the form of the product, its potency, and the quality standards it meets. Oregon limits a single administration to 50 milligrams of psilocybin analyte, and product specifications run against the testing the state requires before product reaches a participant. The contract should require that product pass the mandated laboratory testing for potency and contaminants before delivery, give the buyer the right to reject product that fails or does not meet specification, and assign responsibility for the cost of rejected or non-conforming product.
Chain of custody, transport, and the intrastate limit
Product moves under the state’s tracking system, and the agreement should require both parties to maintain the chain-of-custody records the regulator expects. Transport is itself regulated, so the contract should specify who transports the product, under what security, and who bears the risk while it is in transit. One constraint has no parallel in ordinary supply contracts: the product cannot cross state lines. Federal law and the self-contained design of each state program mean an Oregon service center buys only from Oregon-licensed manufacturers, and a Colorado healing center from Colorado-licensed sources. A supply agreement cannot assume the interstate shipping and sourcing that a standard vendor contract takes for granted.
Payment, title, and risk of loss
The agreement sets the price, the quantity or supply schedule, and the payment terms, all in an environment without standard banking; Banking, payments, and financial services for psychedelic businesses covers how payment actually moves. It should state when title passes and who bears the risk of loss at each stage, because product that is damaged, lost, or seized still has to be accounted for under the tracking rules. Federal tax treatment under Section 280E affects the economics on both sides, though Oregon and Colorado have decoupled their state taxes from it.
Product liability, recalls, and indemnity
If product harms a participant because it was contaminated, mislabeled, or out of specification, the question of who answers for it runs back up the chain. The agreement should allocate that liability, require indemnification for a party’s own failures, and require each party to carry insurance suited to the activity; Insurance for psychedelic businesses: what is available and what is not covers the coverage that may or may not be available. It should also set out recall procedures: how a failed or suspect batch is identified, pulled, and reported, and who bears the cost. A service center that has already administered product from a recalled batch faces downstream questions the supply agreement should anticipate.
Testing agreements with laboratories
A testing agreement engages a licensed laboratory to perform the analyses the state requires, which generally include potency and screens for contaminants such as microbials, heavy metals, pesticides, and residual solvents. The agreement should specify the tests, the methods and standards, the turnaround time, and how results are reported and retained. It should preserve the laboratory’s independence, address the confidentiality of results, and state what happens when a sample fails. Because a passing result is a precondition to product reaching a participant, the timing and reliability of testing carry direct operational weight.
Confidentiality and proprietary methods
Manufacturers may hold proprietary cultivation methods or strains, and the parties exchange business information in the course of supply. The agreement should protect that information, often through confidentiality terms or a separate non-disclosure agreement; Non-disclosure and confidentiality agreements in the psychedelic space covers how those work and their limits.
When public information may be enough
The state agencies publish the rules that define the license types, the testing requirements, the tracking system, and the transport limits a supply agreement must reflect. An operator can read those rules to understand the regulated structure and the questions a supply or testing agreement has to answer. General supply-contract terms are well documented.
When you should speak with a lawyer
The terms that carry the most risk are the licensure conditions, the liability and indemnity allocation, and the recall and rejection provisions, because each turns on how the regulated chain handles a failure. A lawyer can draft a supply or testing agreement that conditions performance on continuing licensure, respects the intrastate limit, and places product-liability risk where the parties intend. An operator entering the supply chain should have these agreements in place before product moves.
You might also want to read
- What legal documents every psychedelic business needs
- Drafting client agreements for psilocybin service centers
- Insurance for psychedelic businesses: what is available and what is not
- Non-disclosure and confidentiality agreements in the psychedelic space
- Banking, payments, and financial services for psychedelic businesses
This article provides general legal information, not legal advice, and does not create an attorney-client relationship. Psychedelic law differs by state and changes over time. Consult a licensed attorney in your jurisdiction before acting on anything described here.